Compare
Guochun International Inc. vs Wewards, Inc. vs Mitesco, Inc. vs Bioregenx, Inc.
| Latest fiscal year | Guochun International Inc. GCGJRevenue covers only part of its income (partial revenue) | Wewards, Inc. WEWA | Mitesco, Inc. MITIRevenue covers only part of its income (partial revenue) | Bioregenx, Inc. BRGX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-05-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $0 | n/a | $1.85M |
| Revenue growth (YoY) | n/a | n/a | n/a | -20.8% |
| Gross margin | n/a | n/a | n/a | 81.1% |
| Operating margin | n/a | n/a | n/a | -67.1% |
| Net margin | n/a | n/a | n/a | -83.2% |
| Net income | -$37.4K | -$497.5K | $498.7K | -$1.54M |
| EPS (Diluted) | n/a | $0.00 | -$0.14 | $0.00 |
| Operating cash flow | -$36.1K | -$60.0K | -$701.6K | $39.0K |
| Free cash flow | n/a | n/a | n/a | $29.9K |
| Cash & equivalents | n/a | $0 | $100.9K | n/a |
| Total assets | $5.5K | $300 | $132.1K | $411.0K |
| Total liabilities | $97.5K | $400 | $23.60M | $4.95M |
| Shareholders' equity | -$92.0K | -$100 | -$23.47M | -$4.54M |
| Return on year-end equity | n/a | n/a | n/a | n/a |
| Shares outstanding | 3.87M | 107.48M | 15.09M | 969.02M |
Revenue, most recent five fiscal years
| Fiscal year | Guochun International Inc. | Wewards, Inc. | Mitesco, Inc. | Bioregenx, Inc. |
|---|---|---|---|---|
| Latest | n/a | $0 Ended 2026-05-31 | n/a | $1.85M Ended 2025-12-31 |
| 1 year earlier | n/a | $0 Ended 2025-05-31 | n/a | $2.34M Ended 2024-12-31 |
| 2 years earlier | n/a | $0 Ended 2024-05-31 | n/a | $3.41M Ended 2023-12-31 |
| 3 years earlier | n/a | $0 Ended 2023-05-31 | n/a | $42.2K Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | n/a | $198.6K Ended 2021-12-31 |